Broadcom Inc (AVGO) Stock Price Today
Aura AI Summary
Key Stats
- $1.80TMARKET_CAP
- -VOLUME
- TechnologySECTOR
- $481.57FIFTY_TWO_WEEK_HIGH
- $264.74FIFTY_TWO_WEEK_LOW
- -TYPICAL_HOLD_TIME
- $1.84TENTERPRISE_VALUE
- 0.69%DIVIDEND_YIELD
- -TRADING_ACTIVITY
Track Broadcom Inc (AVGO) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Broadcom Inc has traded between a low of $264.74 and a high of $481.57, highlighting its annual price range. Buy and sell Broadcom Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Broadcom Inc
Broadcom--the combined entity of Broadcom and Avago--boasts a highly diverse product portfolio across an array of end markets. Avago focused primarily on radio frequency filters and amplifiers used in high-end smartphones, such as the Apple iPhone and Samsung Galaxy devices, in addition to an assortment of solutions for wired infrastructure, enterprise storage, and industrial end markets. Legacy Broadcom targeted networking semiconductors, such as switch and physical layer chips, broadband products (such as television set-top box processors), and connectivity chips that handle standards such as Wi-Fi and Bluetooth. The company has acquired Brocade, CA Technologies, Symantec's enterprise security business, and has a pending deal to acquire VMware to bolster its offerings in software.
Most Recent News
Global pyrometer market to double to $1.15B by 2035, driven by industrial automation and semiconductor growth
The global pyrometer market, valued at $544.55 million in 2025, is projected to reach $1.15 billion by 2035, growing at a CAGR of 7.57%. This growth is fueled by rising industrial automation and expansion in semiconductor manufacturing, which increas...

Ocugen to present gene therapy advances at July 2026 industry conferences
Ocugen, a biotech leader in gene therapies for blindness, announced it will showcase its innovative modifier gene therapy platform at several investor and industry conferences in July 2026. Presentations will cover clinical trial results and regenera...

Deadlines set for lead plaintiff appointments in class action lawsuits against BitGo, ADMA Biologics, and Erasca.
Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against BitGo Holdings, ADMA Biologics, and Erasca. The lawsuits allege these companies made false or misleading statements affe...
